ArticlePloS one2026
Comprehensive chemical, morphological, thermal, and biological characterization of Agave tequilana extract and chitosan-based dissolving microneedle arrays.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dissolving microneedles have gained attention as minimally invasive platforms for transdermal research applications. In this study, chitosan‑based dissolving microneedle arrays incorporating a hydroalcoholic extract of Agave tequilana root were formulated and systematically characterized. Chemical profiling by UHPLC-ESI-Orbitrap-MS revealed a diverse phytochemical composition dominated by phenolic acids, particularly rosmarinic acid. Morphological and structural analyses showed that extract incorporation induced concentration‑dependent changes in microneedle geometry: arrays containing 0.25% extract preserved tip sharpness, whereas a 0.50% loading led to surface roughening and partial tip deformation. Thermal analyses demonstrated extract‑dependent modifications in material degradation behavior, consistent with interactions between chitosan and extract constituents. Biological assays confirmed that the agave extract exhibits high antioxidant capacity, moderate tyrosinase inhibition, and inhibitory activity against collagenase and hyaluronidase. Following incorporation into the microneedle arrays, antioxidant activity and inhibitory effects against tyrosinase and hyaluronidase were retained, while collagenase inhibition was reduced, particularly in the 0.25% formulation. In vitro cytotoxicity assays indicated biocompatibility toward HaCaT keratinocytes and concentration-dependent selective cytotoxicity in A375 melanoma cells. Taken together, these findings indicate that extract loading is a critical parameter influencing structural preservation and in vitro bioactivity of chitosan‑based dissolving microneedles. Further studies addressing mechanical performance, insertion behavior, matrix dissolution, and skin permeation are required to evaluate the functional reliability of this system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.